The 2, 5-dimethoxyamphetamines (2,5-DMA) are a class of designer drugs. They are psychoactive, hallucinogenic stimulants which act as some of the most potent serotonin 5-HT receptor agonists. The psychoactive properties of these drugs are said to range from a stimulant effect at lower doses to hallucinogenic effects at higher doses. Reported adverse effects include tachycardia, seizures, renal failure and delusional psychosis. A complication associated with 2,5-DMA use is severe vasoconstriction, which can cut off circulation to the limbs and extremities, and in some severe cases lead to amputation. 2,5-DMA drugs are reputedly more potent than traditional amphetamines so there is higher risk of overdose.
* EXCLUSIVE to Randox Toxicology
Cross Reactivity
| Analyte |
Compound |
Cross Reactivity %
|
| DOx Series
LOD: 0.8 ng/mL
|
DOB (2,5-dimethoxy-4-bromo-amphetamine) |
100 |
|
Bromo-DragonFLY (HCL) (1-(8-Bromobenzo[1,2-b;4-b]difuran-4-yl)-2-aminopropane)
|
96
|
|
DOI HCI (2,5-dimethoxy-4-iodo-amphetamine)
|
73
|
